Anavex Life Sciences Corp (AVXL)

[falconer66a]

Most Important Statement: Confirms Anavex 2-73 Efficacy

... a nice reporting of Alz patients continuing to do well, after 3 years, on higher dosage of 2-73.

I was not able to connect to hear Missling’s statements, and haven’t found a recording or posting of them yet. But if the good doctor (PhD) made this statement, he formally announced that Anavex is following the Australians with Alzheimer’s who are now in their third year of Anavex 2-73 therapy. The stuff works.

Does this beat the Alzheimer’s Standard of Care (SOC) drug, Aricept (donepezil), the only drug presently available to treat the disease? Sure, donepezil works, moderately, for a time. It will “...provide a temporary reprieve from dementia linked to Alzheimer’s....” It merely slows the progression of the disease. In every case, the debilitating dementia lethally resumes. (Know this personally, as my father died of Alzheimer’s; participated in the drug trial that caused the FDA to approve donepezil’s sale and use.)

If your dad had Alzheimer’s, which drug would you prefer he took. Aricept, a “proven,” well-used therapeutic? Or, Anavex 2-73, which for a good number of Alzheimer’s patients in Australia has stopped the progression of their dementias for neigh on to three years now?

What thoughts go through the minds of health care administrators in Australia, burdened with the caring for of ever greater thousands of elderly people being diagnosed with Alzheimer’s? Aricept? Or Anavex 2-73?

If what Dr. Missling said is so, that Alzheimer’s patients taking sufficient doses of Anavex 2-73 have had the progression of their dementias suppressed for three years, what, then, would be the implication of administering the drug at the very first indications of Alzheimer’s onset? As several have reported, there are a number of new clinical tests and observations that appear to reveal the disease before dementia, itself, is exhibited.

Supports my previous contention that perhaps the greatest therapeutic use of Anavex 2-73 will be as a prophylactic; a drug that prevents both the onset and progression of a disease.)

Sometime soon In a physician’s office? “Mr. Dorglemyer, I’ve just reviewed the numbers from your checkup we did last week. They show that you are coming down with Alzheimer’s. But fortunately, there is this new drug, blarcamesine [Anavex 2-73], which I’ll prescribe for you. Your insurance will pay for it. It’ll keep your mind clear on out. Just be sure to take the tablet every morning. So glad we found your Alzheimer’s so soon, and now, thankfully, have a drug that will allow you to live normally for the rest of your life.”

Perhaps the first Mr. Dorglemyer will be some fellow in Australia; where Anavex 2-73 first gets regulatory approval for therapeutic use.